EA200100094A1 - ЗАМЕЩЕННЫЕ β-ДИКЕТОНЫ И ИХ ПРИМЕНЕНИЕ - Google Patents

ЗАМЕЩЕННЫЕ β-ДИКЕТОНЫ И ИХ ПРИМЕНЕНИЕ

Info

Publication number
EA200100094A1
EA200100094A1 EA200100094A EA200100094A EA200100094A1 EA 200100094 A1 EA200100094 A1 EA 200100094A1 EA 200100094 A EA200100094 A EA 200100094A EA 200100094 A EA200100094 A EA 200100094A EA 200100094 A1 EA200100094 A1 EA 200100094A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
relates
diseases
halogen
hydrogen
Prior art date
Application number
EA200100094A
Other languages
English (en)
Other versions
EA002693B1 (ru
Inventor
Пяйви Ахо
Рейо Бякстрем
Анита Копонен
Инге-Бритт Линден
Тимо Лотта
Кари Леннберг
Айно Пиппури
Пентти Похто
Original Assignee
Орион Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орион Корпорейшн filed Critical Орион Корпорейшн
Publication of EA200100094A1 publication Critical patent/EA200100094A1/ru
Publication of EA002693B1 publication Critical patent/EA002693B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Detergent Compositions (AREA)
  • Paper (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Stringed Musical Instruments (AREA)
  • Materials For Medical Uses (AREA)
  • Tents Or Canopies (AREA)

Abstract

Изобретение относится к соединениям формулы (I), в которой один из Xи Xявляется MeSO, а другой является водородом или галогеном и Xявляется водородом или галогеном. Было найдено, что эти соединения являются полезными для предотвращения или профилактики и лечения респираторных заболеваний, особенно астмы, ARDS (острого респираторного дистресс-синдрома), COPD (хронических обструктивных легочных заболеваний), аллергического ринита и родственных воспалительных состояний. Более конкретно, изобретение относится к применению указанных соединений при профилактике и лечении астмы пациентов, стойких к действию стероидов. Изобретение относится также к лекарственным препаратам, применяемым при лечении названных заболеваний.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100094A 1998-07-01 1999-06-30 ЗАМЕЩЕННЫЕ β-ДИКЕТОНЫ И ИХ ПРИМЕНЕНИЕ EA002693B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI981521A FI981521A0 (fi) 1998-07-01 1998-07-01 Substituoidut beta-diketonit ja niiden käyttö
PCT/FI1999/000575 WO2000001667A1 (en) 1998-07-01 1999-06-30 SUBSTITUTED β-DIKETONES AND THEIR USE
US09/346,397 US6201027B1 (en) 1998-07-01 1999-07-01 Substituted β diketones and their use

Publications (2)

Publication Number Publication Date
EA200100094A1 true EA200100094A1 (ru) 2001-06-25
EA002693B1 EA002693B1 (ru) 2002-08-29

Family

ID=26160612

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100094A EA002693B1 (ru) 1998-07-01 1999-06-30 ЗАМЕЩЕННЫЕ β-ДИКЕТОНЫ И ИХ ПРИМЕНЕНИЕ

Country Status (29)

Country Link
US (1) US6201027B1 (ru)
EP (1) EP1091933B1 (ru)
JP (1) JP2002519407A (ru)
CN (1) CN1258526C (ru)
AT (1) ATE255088T1 (ru)
AU (1) AU745338B2 (ru)
BG (1) BG64529B1 (ru)
BR (1) BR9911626A (ru)
CA (1) CA2336300A1 (ru)
CZ (1) CZ296378B6 (ru)
DE (1) DE69913145T2 (ru)
DK (1) DK1091933T3 (ru)
EA (1) EA002693B1 (ru)
EE (1) EE200000789A (ru)
ES (1) ES2212590T3 (ru)
FI (1) FI981521A0 (ru)
HK (1) HK1036054A1 (ru)
HR (1) HRP20000911B1 (ru)
HU (1) HUP0103006A3 (ru)
IL (1) IL139963A0 (ru)
IS (1) IS2037B (ru)
NO (1) NO20006665D0 (ru)
PL (1) PL195216B1 (ru)
PT (1) PT1091933E (ru)
SI (1) SI1091933T1 (ru)
SK (1) SK284934B6 (ru)
TR (1) TR200003773T2 (ru)
WO (1) WO2000001667A1 (ru)
ZA (1) ZA200006961B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049660A1 (en) * 1999-12-30 2001-07-12 Orion Corporation A process for preparing 3-{[3-chloro-4-(methylsulfonyl)-phenyl]methylene}-2,4-pentanedione
FI20011386A0 (fi) * 2001-06-28 2001-06-28 Orion Corp Inhalaatiopartikkeleja
FI20020126A0 (fi) * 2002-01-23 2002-01-23 Orion Corp Koostumuksia pulmonaaliseen antoon
CA2841859C (en) * 2011-07-12 2021-03-09 Astrazeneca Ab N- (6- ( (2r,3s) -3,4-dihydroxybutan-2-yloxy) -2- (4 - fluorobenzylthio)pyrimidin- 4 - yl) -3- methylazetidine- 1 - sulfonamide as chemokine receptor modulator

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230767A (ja) 1985-08-01 1987-02-09 Taisho Pharmaceut Co Ltd イミダゾ−ル誘導体
US4741769A (en) 1986-06-09 1988-05-03 Stauffer Chemical Company Certain 1-phenyl-3-alkyl-1,3-propanediones
YU213587A (en) 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
MTP1031B (en) 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
IL91382A (en) 1988-09-01 1995-06-29 Orion Yhtymae Oy Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them
US5804532A (en) * 1991-01-25 1998-09-08 Rhone-Poulenc Agriculture Limited Herbicidal 2-cyano-1,3-diones

Also Published As

Publication number Publication date
BG64529B1 (bg) 2005-06-30
ES2212590T3 (es) 2004-07-16
HK1036054A1 (en) 2001-12-21
HUP0103006A3 (en) 2002-12-28
FI981521A0 (fi) 1998-07-01
CN1307559A (zh) 2001-08-08
AU745338B2 (en) 2002-03-21
CA2336300A1 (en) 2000-01-13
NO20006665L (no) 2000-12-27
CN1258526C (zh) 2006-06-07
SI1091933T1 (en) 2004-04-30
BG105080A (en) 2001-09-28
BR9911626A (pt) 2001-03-20
WO2000001667A1 (en) 2000-01-13
ZA200006961B (en) 2001-08-10
US6201027B1 (en) 2001-03-13
DE69913145T2 (de) 2004-09-02
EA002693B1 (ru) 2002-08-29
DK1091933T3 (da) 2004-03-22
HUP0103006A2 (hu) 2002-03-28
SK284934B6 (sk) 2006-02-02
CZ296378B6 (cs) 2006-03-15
SK19852000A3 (sk) 2002-05-09
NO20006665D0 (no) 2000-12-27
AU5039299A (en) 2000-01-24
CZ20004774A3 (en) 2001-06-13
PT1091933E (pt) 2004-04-30
PL195216B1 (pl) 2007-08-31
TR200003773T2 (tr) 2001-06-21
PL344856A1 (en) 2001-11-19
IS5793A (is) 2000-12-27
EP1091933A1 (en) 2001-04-18
EE200000789A (et) 2002-06-17
HRP20000911B1 (en) 2006-07-31
ATE255088T1 (de) 2003-12-15
DE69913145D1 (de) 2004-01-08
IS2037B (is) 2005-08-15
JP2002519407A (ja) 2002-07-02
EP1091933B1 (en) 2003-11-26
IL139963A0 (en) 2002-02-10
HRP20000911A2 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
ATE183647T1 (de) Methode zur behandlung von entzündungen der lunge
ATE276749T1 (de) Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung
SE0200356D0 (sv) Novel use
PT1252157E (pt) Carboxamidas de pirimidina uteis como inibidores de isozimas pde4
NO20005887D0 (no) Forbindelser med IgE-påvirkende egenskaper
BR0211468A (pt) Métodos de tratar e de prevenir uma doença inflamátoria em um mamìfero e de identificar um composto útil para tratar uma doença inflamatória em um mamìfero, composto, e kits para tratar e para prevenir uma doença inflamatória em um mamìfero
HUP0401501A2 (hu) Érrendszeri gyulladás kezelése vagy megelőzése szterin-felszívódást gátló anyagokat tartalmazó gyógyszerkészítmények alkalmazásával
EA200500803A1 (ru) Антагонисты ccr1 для лечения воспалительных артритов, демиелинизационных воспалительных заболеваний
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
EA200100094A1 (ru) ЗАМЕЩЕННЫЕ β-ДИКЕТОНЫ И ИХ ПРИМЕНЕНИЕ
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
NO975028L (no) Piperazinoderivater som neurokininantagonister
EA200200518A1 (ru) Способ и композиция для лечения заболеваний легких
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
DE60323973D1 (de) Verwendung von glykosaminglykanen wie z.b. heparin zur behandlung von atemerkrankungen wie copd
WO2002083700A3 (en) Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
NO20030137D0 (no) Fremgangsmåte for behandling av ustabil angina pectoris
YU78800A (sh) Supstituisani beta-diketoni i njihova upotreba
DE60026581D1 (de) Indolderivate zur behandlung von depression und angstzuständen
SE9901273D0 (sv) Novel compounds
Das et al. CSP7 Mitigates TSE Induced Airway Injury and Susceptibility to Develop Emphysema
WO2021170880A3 (en) Anti-adrenomedullin (adm) binder for use in therapy of patients in shock